Skin Microbiome East 2019 | Kisaco Research
Translating microbiome research into clinically & commercially viable cosmetics & therapeutics, revolutionizing dermatology.
Boston, USA
29-30 May, 2019
Download Agenda
The Audience
Register

Why Attend

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.

Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.

Join 250+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.

Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: 

  • Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application
  • Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome
  • Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome
  • Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics
  • Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products
  • Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product

With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

2
Full conference days
25+
Industry Speakers
100+
Beauty & pharma experts
15+
Dedicated networking hours

Who Will Be There

15%
Multinational Beauty & Personal Care Companies
15%
Multinational Pharmaceutical Companies
60%
Skincare Brands & Biotechnology Companies
5%
Formulators, Ingredients Suppliers & Packaging Manufacturers
5%
Sequencing Companies & Solution Providers

Multinational Beauty & Personal Care Companies

Multinational Pharmaceutical Companies

Skincare Brands & Biotechnology Companies

Formulators, Ingredients Suppliers & Packaging Manufacturers

Sequencing Companies & Solution Providers

Past Speakers Included

 

Cécile Clavaud

Project Leader
Skin Microbiome Unit, L'oreal Research & Innovation

Cécile Clavaud

Project Leader
Skin Microbiome Unit, L'oreal Research & Innovation
 

Marie Drago

Founder
Gallinee

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie Drago

Founder
Gallinee

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie’s thesis on the microbiome and the enormous benefits of harnessing helpful bacteria gave her the vision and the know-how to create Gallinée’s formulations. Thanks to her pharmacy background and her beauty experience, Marie designed formulas like no other, and patented the triple biotic complex that you can now find in Gallinée’s products.

 

 

David Tyrrell

Global Skincare Analyst
Mintel

David’s experience in skincare has spanned over 15 years. During his tenure at Kimberly-Clark he held positions in Corporate Research, New Product Development and Technology Scouting & Alliance Management. He has been active in identifying a variety of consumer and medical device technologies and products for in-licensing and led international research efforts in the biological characterization of naturally sourced skincare ingredients. David has a BS in Chemistry and a PhD in Biochemistry.

David Tyrrell

Global Skincare Analyst
Mintel

David’s experience in skincare has spanned over 15 years. During his tenure at Kimberly-Clark he held positions in Corporate Research, New Product Development and Technology Scouting & Alliance Management. He has been active in identifying a variety of consumer and medical device technologies and products for in-licensing and led international research efforts in the biological characterization of naturally sourced skincare ingredients. David has a BS in Chemistry and a PhD in Biochemistry.

 

Dirk Loeffert

CEO
Biomillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences.

Dirk Loeffert

CEO
Biomillenia

Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences. In 2014, Dirk moved to Paris, France where he co-founded with scientific founders Dave Weitz (Harvard University, Cambridge), Rob Nicol (BROAD Institute, Cambridge) and Andrew Griffiths and Jerome Bibette (both ESPCI Paris, France) BIOMILLENIA.

 

Dr. Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

Dr. Chris Callewaert

Post-doctoral researcher
Centre for Microbial Ecology & Technology, Ghent University

Chris received his PhD from Ghent University in Belgium. He is now a postdoctoral research fellow in the Knight lab at the University of California, San Diego. He investigates body odor and the characteristics of the bacteria living in the armpits, skin, clothes, washing machines and homes. He is the first to undertake bacterial transplants to solve underarm body odour.

 

Dr. Nick Monsul

Founder & Chairman
Quorum Innovations
Dr. Monsul was born in Philadelphia and graduated from Drexel University. He completed his medical degree at Hahnemann University, Drexel University College of Medicine. His ophthalmology residency at Yale University was followed by fellowship programs at The Johns Hopkins Hospital, The Wilmer Eye Institute and Allegheny General Hospital in Pittsburgh. He moved to Florida in 2003. Throughout his career and education, he has been involved in basic science research with a particular interested in neural regeneration and neuronal cell death. In addition to his roles at Quorum Innovations where he is actively involved in the research program, he is a surgeon with a busy practice in the Hawthorne Clinic and Research Center.

Dr. Nick Monsul

Founder & Chairman
Quorum Innovations

Dr. Monsul was born in Philadelphia and graduated from Drexel University.  He completed his medical degree at Hahnemann University, Drexel University College of Medicine.  His ophthalmology residency at Yale University was followed by fellowship programs at The Johns Hopkins Hospital, The Wilmer Eye Institute and Allegheny General Hospital in Pittsburgh.  He moved to Florida in 2003.  Throughout his career and education, he has been involved in basic science research with a particular interested in neural regeneration and neuronal cell death.  In addition to his roles at Quorum Innovations where he is actively involved in the research program, he is a surgeon with a busy practice in the Hawthorne Clinic and Research Center.

 

Dr. Roshini Raj

Co-Founder
TULA

Dr. Roshini Raj is a board certified gastroenterologist and internist with a medical degree from New York University School of Medicine and an undergraduate degree from Harvard College.

She is an Associate Professor of Medicine at NYU School of Medicine, and an Attending Physician at NYU Langone Medical Center. Dr. Raj has a special interest in women’s health and cancer screening and has published several research articles on colon cancer screening.

Dr. Roshini Raj

Co-Founder
TULA

Dr. Roshini Raj is a board certified gastroenterologist and internist with a medical degree from New York University School of Medicine and an undergraduate degree from Harvard College.

She is an Associate Professor of Medicine at NYU School of Medicine, and an Attending Physician at NYU Langone Medical Center. Dr. Raj has a special interest in women’s health and cancer screening and has published several research articles on colon cancer screening.

Dr. Raj is a TODAY Show contributor, the Dr. Oz Show core expert, the Good Day NY Medical Correspondent (Fox5) and the Medical Editor of Health Magazine. In August 2010, she released her first book, What the Yuck?! The Freaky & Fabulous Truth About Your Body. Dr. Raj has discussed a wide variety of health topics on a range of network and cable shows, including NBC’s Today Show; ABC’s The View, LIVE with Kelly and Michael, Good Morning America and World News Tonight; CNN’s American Morning, Nancy Grace, and Larry King Live; The Discovery Health Channel; The Tyra Banks Show; bethenny and The Doctors, among others.

Dr. Raj has been quoted in several publications, including The New York Times, The Wall Street Journal, Cosmopolitan, Men’s Health, Women’s Health and Fitness for her knowledge of the state of healthcare and the latest health news.

Recognizing the need for women to achieve balance in life, Dr. Raj recently co-founded TULA, a healthy-living brand launched in July 2014 with a new skin care line that uses a patented probiotic technology, the first of a series of healthy-living products.

In April 2014, Dr. Raj was appointed by Lose It!, a leading consumer weight loss program, to its Newley Formed Expert Advisory Board, where she will play a critical role in providing the users with the most effective weight loss program available.

Dr. Raj resides in New York City with her husband and two children.

 

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance

Jasmina Aganovic

President
Mother Dirt

Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance of the skin biome. The technology is based off research from AOBiome Therapeutics, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT. Her career path combined her technical background with roles at consumer brands like LVMH, Fresh, and Living Proof. 

 

Jason Harcup

Global Vice President Personal Care Research and Global Vice President Prestige Division R&D
Unilever

Dr. Jason Harcup is Global Vice President for Personal Care Research, responsible for Unilever’s worldwide research program across its €20 Billion Personal Care businesses in Skin Care and Cleansing, Hair and Scalp, Deodorants, Oral Care and also delivering to the Prestige Division. He has ultimate responsibility for several hundred mostly PhD level scientists located in 5 laboratories across the USA, Europe, India and China. He is located in Unilever’s UK research hub.

Jason Harcup

Global Vice President Personal Care Research and Global Vice President Prestige Division R&D
Unilever

Dr. Jason Harcup is Global Vice President for Personal Care Research, responsible for Unilever’s worldwide research program across its €20 Billion Personal Care businesses in Skin Care and Cleansing, Hair and Scalp, Deodorants, Oral Care and also delivering to the Prestige Division. He has ultimate responsibility for several hundred mostly PhD level scientists located in 5 laboratories across the USA, Europe, India and China. He is located in Unilever’s UK research hub. In 18 years with Unilever, he has been Site Leader for the brand new €60million Shanghai R&D Facility and headed Unilever’s Research organization in China, growing the facility capability together with a two dozen strong network of Chinese Academic Institutes.

 

Julia Oh

Assistant Professor
The Jackson Laboratory

Dr. Oh's main research interests focus on the human microbiome—the diverse bacteria, fungi, and viruses that inhabit our bodies—for its potential to deliver treatments for infectious and other diseases.  Dr. Oh comes to the microbiome world by way of fungal chemogenomics with technologist and geneticist Dr. Ronald Davis at Stanford and comparative genomics of wild wine yeast at the FAS Center for Systems Biology at Harvard. Prior to joining the Jackson Laboratory, she was a postdoctoral fellow at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health. Dr.

Julia Oh

Assistant Professor
The Jackson Laboratory

Dr. Oh's main research interests focus on the human microbiome—the diverse bacteria, fungi, and viruses that inhabit our bodies—for its potential to deliver treatments for infectious and other diseases.  Dr. Oh comes to the microbiome world by way of fungal chemogenomics with technologist and geneticist Dr. Ronald Davis at Stanford and comparative genomics of wild wine yeast at the FAS Center for Systems Biology at Harvard. Prior to joining the Jackson Laboratory, she was a postdoctoral fellow at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health. Dr. Oh's research, exploring the complex interactions between the host and its microbes has lead to important implications for the contribution of the microbiome to disease.

 

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin.

Kimberly Capone

Research Fellow Lead Microbiologist for Skin Microbiome Research
Johnson & Johnson Consumer Companies

Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin. In the course of her work, Dr. Capone has authored numerous peer-reviewed papers and has participated in national and international dermatology conferences. 

 

Lada Rasochova

CEO
Dermala Inc.

Lada is the founder and CEO of Dermala Inc. Lada is an experienced business executive as well as scientist by training. She has been involved in commercialization of pharmaceutical and biotechnology products for the past 20 years. She spent more than 15 years in biotech and pharma industry where she held various management and leadership positions, including as the director of new business development in the Dowpharma division of the Dow Chemical Company. Prior to Dow, she was with Mycogen, a biotechnology startup that was acquired by Dow Chemical.

Lada Rasochova

CEO
Dermala Inc.

Lada is the founder and CEO of Dermala Inc. Lada is an experienced business executive as well as scientist by training. She has been involved in commercialization of pharmaceutical and biotechnology products for the past 20 years. She spent more than 15 years in biotech and pharma industry where she held various management and leadership positions, including as the director of new business development in the Dowpharma division of the Dow Chemical Company. Prior to Dow, she was with Mycogen, a biotechnology startup that was acquired by Dow Chemical. Lada came back to academia in 2009 and joined the Rady School of Management at UC San Diego with the goal to increase commercialization outcomes through education, mentorship, and startup infrastructure. She founded the California Institute for Innovation and Development (CIID) that serves as an entrepreneurship hub, the Rady Venture Fund, a VC fund (where she is the managing director) that invests in early stage technology companies, StartR accelerator that provides support to emerging startups, and award winning mystartupXX accelerator that supports female-led technology startups. As a result, more than 150 startup companies were founded by the Rady School students and alumni to date. Lada is the recipient of numerous awards including most recently the Athena Pinnacle Award (2014), Most Innovative Thinkers award (2016), and San Diego 500 Influential Business Leaders awards (2017).

 

Mark Wilson

President & CEO
MatriSys BioScience

Mark Wilson

President & CEO
MatriSys BioScience
 

Mingxun Wang

CEO
Ometa Labs

I am a PhD candidate at UCSD. My research interests are in bioinformatics and more specifically, I focus on computational mass spectrometry. At UCSD I have the honor of being advised by Nuno Bandeira

Prior to coming to San Diego, I attended the University of Illinois for my undergraduate degree in Computer Engineering. However, it was in Missouri that I spent my most impressionable years.

Mingxun Wang

CEO
Ometa Labs

I am a PhD candidate at UCSD. My research interests are in bioinformatics and more specifically, I focus on computational mass spectrometry. At UCSD I have the honor of being advised by Nuno Bandeira

Prior to coming to San Diego, I attended the University of Illinois for my undergraduate degree in Computer Engineering. However, it was in Missouri that I spent my most impressionable years.

 

Riëtte van Laack

Director
Hyman, Phelps, & McNamara, P.C.

Riëtte van Laack, Ph.D., provides regulatory counsel on OTC products, including foods and dietary supplements, OTC drugs, cosmetics, and animal feed and drugs on a range of FDA, USDA, FTC, and CPSC issues.

Riëtte van Laack

Director
Hyman, Phelps, & McNamara, P.C.

Riëtte van Laack, Ph.D., provides regulatory counsel on OTC products, including foods and dietary supplements, OTC drugs, cosmetics, and animal feed and drugs on a range of FDA, USDA, FTC, and CPSC issues.

Ms. van Laack has substantial experience with food and dietary supplement issues, labeling and advertising. She counsels clients regarding GMP and HACCP compliance issues, Reportable Food Registry issues, and responses to warning letters. Ms. van Laack advises clients on regulatory strategy, including requirements pertaining to self-determinations of GRAS status and determinations of new dietary ingredient status.  Ms. van Laack also has substantial experience with regulation regarding labeling and advertising of over-the-counter (OTC) drugs and cosmetics. Ms. van Laack’s practice includes USDA regulatory issues ranging from requirements for import of animal products (APHIS), use of ingredients in meat, poultry, and egg products (FSIS), and organic labeling requirements (AMS).  Ms. van Laack conducts due diligence evaluations of FDA- and USDA-regulated companies. She additionally assists clients with compliance and liability issues related to products regulated both by the CPSC and FDA.

Ms. van Laack has advanced degrees in Nutrition and Meat Science, and more than 15 years experience in food research.   Ms. van Laack was a professor at the Department of Food Science and Technology at the University of Tennessee.  While in law school, Ms. van Laack was an Articles Editor of theTennessee Law Review.

 

 

Thomas Hitchcock

CEO & Founder
Xycrobe Therapeutics

Thomas Hitchcock is the founder and CEO of Xycrobe Therapeutics. An entrepreneur in the biotech space, Thomas has been instrumental in bringing several medical technologies successfully to the dermatological and aesthetics markets.  Thomas holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair.

Thomas Hitchcock

CEO & Founder
Xycrobe Therapeutics

Thomas Hitchcock is the founder and CEO of Xycrobe Therapeutics. An entrepreneur in the biotech space, Thomas has been instrumental in bringing several medical technologies successfully to the dermatological and aesthetics markets.  Thomas holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair. He has completed postdoctoral training at both Duke University in the Biomedical Engineering Department and Yale University in the Program in Vascular Biology and Therapeutics where he was involved in ground-breaking research and development of in vitro engineered human cardiovascular and pulmonary tissues. He has also performed research at Weill Cornell Medical College in the Department of Oncology and Hematology where he studied multiple myeloma genetics. Prior to Xycrobe, he was the Director of Medical Affairs for Ulthera, Inc., and part of the team that brought their platform technology to acquisition in July 2014 by Merz pharmaceuticals. Thomas also currently travels the country lecturing to medical professionals about skincare and aesthetics in dermatology.

 

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

Travis Whitfill

Co-Founder and Chief Scientific Officer
Azitra

Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.

His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States. 

 

Trevor Steyn

Founder
Esse Organic Skincare

Trevor is an organic chemist with a passion to explore new ways of treating skin and fighting ageing.

For more than 15 years his research on skin has taken a very different approach. He takes a broad, long-term perspective to anti-ageing and looks at every aspect of the skin, from its health to the external factors affecting it.

Trevor Steyn

Founder
Esse Organic Skincare

Trevor is an organic chemist with a passion to explore new ways of treating skin and fighting ageing.

For more than 15 years his research on skin has taken a very different approach. He takes a broad, long-term perspective to anti-ageing and looks at every aspect of the skin, from its health to the external factors affecting it.

Esse was born in 2002 as a result of Trevor’s passion for the chemistry of Africa’s plants. His post-graduate research was about the extraction of active compounds from African plants. After discovering the potential of these plants in skincare products, Trevor founded Esse Probiotic Skincare.

 

 

Kit Wallen-Russell

Director, R&D
JooMo Ltd

With a Masters Degree in Geophysics from University College London (UCL), twice published scientific author, and JooMo Co-Founder Kit published a peer-reviewed paper in 2017 that describes the first ever mechanism to determine whether skin is healthy or not. As director of the Pavane Research Centre (the R&D arm behind all ground-breaking JooMo technology), he discovered that the ONLY indicator of healthy skin was high microbial biodiversity, not the presence/lack of particular microbes.

Kit Wallen-Russell

Director, R&D
JooMo Ltd

With a Masters Degree in Geophysics from University College London (UCL), twice published scientific author, and JooMo Co-Founder Kit published a peer-reviewed paper in 2017 that describes the first ever mechanism to determine whether skin is healthy or not. As director of the Pavane Research Centre (the R&D arm behind all ground-breaking JooMo technology), he discovered that the ONLY indicator of healthy skin was high microbial biodiversity, not the presence/lack of particular microbes. The immense power of his discovery meant that, for the first time, it was possible to determine whether everyday cosmetics really are the primary cause of the skin allergy epidemic that’s raging across the western world. To do so, Kit formed a partnership with top European institution, The Medical University of Graz, to test everyday cosmetics, including JooMo, for their effect on skin health. The extremely intriguing results from the seminal study will have been published by Kit at the time of the event. Both Kit and Nick aim to dispel the myths and ill-education surrounding Probiotics within the industry, and distance JooMo from the Pro-/Pre- Biotics label. JooMo is NOT a probiotic.

 

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Dr. Rainer Simmering is a Senior Scientist in the Corporate Microbiology group of Henkel AG & Co. KGaA in Düsseldorf. After finalizing his study of biology at the WWU in Muenster, he conducted a PhD at the German Institute of Human Nutrition in Potsdam, where he also stayed for another year as a Post-Doc.

In October 2000, he started at the Nestlé Research Center in Lausanne, where he was working on the detection and function of the intestinal microbiota.

Rainer Simmering

Senior Scientist, Corporate Microbiology
Henkel AG & Co, KGaA

Dr. Rainer Simmering is a Senior Scientist in the Corporate Microbiology group of Henkel AG & Co. KGaA in Düsseldorf. After finalizing his study of biology at the WWU in Muenster, he conducted a PhD at the German Institute of Human Nutrition in Potsdam, where he also stayed for another year as a Post-Doc.

In October 2000, he started at the Nestlé Research Center in Lausanne, where he was working on the detection and function of the intestinal microbiota.

In 2003 he came to Henkel, where he worked, in the group of Hygiene Research, on different research projects, like the elucidation of the skin microbiota with molecular means. Since mid of 2009 Dr. Simmering acts as an internal consultant for the global Beauty Care business regarding all microbiological questions.

 

Dr Linda M. Katz

Director, Office of Cosmetics and Colors
FDA

Dr. Linda Katz is the Director for the Office of Cosmetics and Colors (OCAC), in FDA’s Center of Foods and Applied Nutrition (CFSAN); a position that she has held since 2002, and the Interim Chief Medical Officer for CFSAN. Dr. Katz establishes the priorities and missions of OCAC focusing on cosmetic safety, compliance, certification of color additives, and research such as nanotechnology, phototoxicity and percutaneous absorption, and addresses safety and medical concerns for CFSAN regulated products. Dr.

Dr Linda M. Katz

Director, Office of Cosmetics and Colors
FDA

Dr. Linda Katz is the Director for the Office of Cosmetics and Colors (OCAC), in FDA’s Center of Foods and Applied Nutrition (CFSAN); a position that she has held since 2002, and the Interim Chief Medical Officer for CFSAN. Dr. Katz establishes the priorities and missions of OCAC focusing on cosmetic safety, compliance, certification of color additives, and research such as nanotechnology, phototoxicity and percutaneous absorption, and addresses safety and medical concerns for CFSAN regulated products. Dr. Katz is the Agency’s liaison for nanotechnology issues pertaining to food and cosmetics. She is a member of the FDA Nanotechnology Task Force and other FDA nanotechnology working groups, as well as being an active member of CFSAN’s Leadership Board, and other CFSAN and FDA management committees. She has had numerous presentations and publications, including those related to nanotechnology regarding cosmetics and foods issues, and other specific cosmetic topics. Prior to assuming leadership of the Office of Cosmetics and Colors, Dr. Katz held positions in the FDA’s Center for Drug Evaluation and Research (CDER) as Deputy Director for the Division of Over-the-Counter Drug Products, Deputy Director for the Division of Dermatologic and Dental Drug Products, and Team Leader and Acting Director for the Pilot Drug Evaluation Staff.

Dr. Katz received her B.A. in biology from the University of Pennsylvania; a M.P.H. in epidemiology from the University Of Michigan School Of Public Health, and a M.D. from the University of Connecticut. She completed her internship and residency in Internal Medicine, and fellowship in Rheumatology at the George Washington University Medical Center, in Washington, D.C.

 

Dr Marie Alice Dibon

Owner
Alice Communications

Dr Marie Alice Dibon currently heads Alice Communications Inc. a consulting company, servicing various industries on strategy, business development, communication and innovation and established in 2000.

Before the creation of Alice Communications, Dr Dibon spent 15 years in France and the United States in the beauty, pharmaceutical and medical device industries. Her experience ranges from product development to marketing, through regulatory affairs, business development and manufacturing.

Dr Marie Alice Dibon

Owner
Alice Communications

Dr Marie Alice Dibon currently heads Alice Communications Inc. a consulting company, servicing various industries on strategy, business development, communication and innovation and established in 2000.

Before the creation of Alice Communications, Dr Dibon spent 15 years in France and the United States in the beauty, pharmaceutical and medical device industries. Her experience ranges from product development to marketing, through regulatory affairs, business development and manufacturing.

Today Alice Communications focuses on promoting and deciphering science and  innovative technologies with industry and consumers for the benefit of the patient, consumer or industrial actors.

Ms. Dibon holds a Masters in Industrial Pharmacy Institute of the Industrial Pharmacy Institute in Lyon and a Doctorate in Pharmacy from the Institute of Pharmaceutical and Biological Sciences of Lyon. She contributes regularly as an editor in the trade press on the topics of innovation, communication, science and technology, and their societal impacts.

 

Denis Wahler, PhD

Global Manager Technology Partnerships
Givaudan Active Beauty

An experienced manager for collaborative research and development, Denis is in charge of Technology Partnerships within the Active Beauty business unit of Givaudan. Prior to this role, he was Business Development Manager in biocatalysis and metagenomics at Libragen, before the acquisition of the company by Givaudan in 2015. Libragen has since become the Applied Microbiomics Centre of Excellence of Givaudan Active Beauty.

Denis Wahler, PhD

Global Manager Technology Partnerships
Givaudan Active Beauty

An experienced manager for collaborative research and development, Denis is in charge of Technology Partnerships within the Active Beauty business unit of Givaudan. Prior to this role, he was Business Development Manager in biocatalysis and metagenomics at Libragen, before the acquisition of the company by Givaudan in 2015. Libragen has since become the Applied Microbiomics Centre of Excellence of Givaudan Active Beauty. Graduated from a PhD in Chemistry and Biochemistry at the University of Bern, Switzerland, Denis specialized in applied research and contract services in white biotechnology and green chemistry at Proteus/PCAS Biosolution, where he served as Head of R&D and Scientific Manager for many years. Prior to joining Libragen, he also spent one and a half year at SEPPIC (Air Liquide Group) as Head of the Synthesis Department.

 

Nick Wallen

Founder
JooMo Ltd

With a background in chemistry, microelectronics and IT, Manchester University graduate Nick Wallen co-created JooMo to answer the paradox of why there’s a skin allergy epidemic raging across the wealthy Western world. His research led him to the disturbing conclusion that chemicals in everyday cosmetics could be a primary cause. These ingredients altered the skin’s natural ecosystem, and even so-called ‘natural’ cosmetics contained these dangerous additives. Determined to clean up the industry, Nick invented, JooMo, the world's first ever 100% natural and preservative free face wash.

Nick Wallen

Founder
JooMo Ltd

With a background in chemistry, microelectronics and IT, Manchester University graduate Nick Wallen co-created JooMo to answer the paradox of why there’s a skin allergy epidemic raging across the wealthy Western world. His research led him to the disturbing conclusion that chemicals in everyday cosmetics could be a primary cause. These ingredients altered the skin’s natural ecosystem, and even so-called ‘natural’ cosmetics contained these dangerous additives. Determined to clean up the industry, Nick invented, JooMo, the world's first ever 100% natural and preservative free face wash. JooMo's cutting edge skin bacteria technology restores the skin’s natural biodiversity, enabling the skin to heal itself. Ahead of his time, Nick has been researching the little-studied subject of the Skin Microbiome since 2011, with JooMo aiming high as the 'first company to move the science of the gut to the skin'. His aim is to revolutionise the industry into an honest, research-driven and health-giving one, and says currently, it is 'a skin-damaging, dishonestly labelled one not backed up by science'.

 

Marisa Meloni

CEO
VitroScreen

Marisa Meloni got a PhD in Drug Delivery and Cutaneous Bio-physic at Renée Descartes University, Paris V (France). Thereafter, she was in charge for research and innovation within the dermo-pharmaceutical and cosmetic industry for 15 years. During that period, she also was contract professor of safety assessment and technology of cosmetic products at Milan, Salerno and Padua Universities.

Marisa Meloni

CEO
VitroScreen

Marisa Meloni got a PhD in Drug Delivery and Cutaneous Bio-physic at Renée Descartes University, Paris V (France). Thereafter, she was in charge for research and innovation within the dermo-pharmaceutical and cosmetic industry for 15 years. During that period, she also was contract professor of safety assessment and technology of cosmetic products at Milan, Salerno and Padua Universities.

In 2001, she created VitroScreen, a research laboratory committed to in vitro science that has the mission to be a reference partner for companies approaching in vitro alternatives, providing in vitro pre-clinical efficacy and regulatory toxicological services.

At VitroScreen she has developed “mechanism based experimental models“ on 3D reconstructed human tissue models for active ingredients and finished product testing: this approach better mimics the in vivo skin and epithelia response taking into account the dynamic of the biological response. VitroScreen is GLP certified and a member of the EU-Netval national reference laboratory network.

 

Dana Hosseini

CEO and Co-Founder
ProdermIQ, Inc

A serial entrepreneur who has managed and co-founded a number of genomics-based companies including, ProdermIQ, Iceland Genomics and DiThera. Mr. Hosseini's skills in international medical device/diagnostic sales and marketing were developed at Abbott Laboratories, Ortho Clinical Diagnostics (Johnson & Johnson) and Sequenom, where he held executive and management positions in business development, and sales and marketing functions. He has 25+ years of extensive experience working with global biotech, pharmaceutical companies and healthcare providers. He received both his B.Sc.

Dana Hosseini

CEO and Co-Founder
ProdermIQ, Inc

A serial entrepreneur who has managed and co-founded a number of genomics-based companies including, ProdermIQ, Iceland Genomics and DiThera. Mr. Hosseini's skills in international medical device/diagnostic sales and marketing were developed at Abbott Laboratories, Ortho Clinical Diagnostics (Johnson & Johnson) and Sequenom, where he held executive and management positions in business development, and sales and marketing functions. He has 25+ years of extensive experience working with global biotech, pharmaceutical companies and healthcare providers. He received both his B.Sc. and MBA from the University of British Columbia.

Past Agenda

Simply fill in this form we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.

We've received great feedback on other similar events...

3rd Annual European Microbiome Congress: The Next Big Thing in Microbiome...Skin

Beauty & Money Summit 2017

Download Past Agenda

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Become a Sponsor

Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.